Targeting the gut microbiome preoperatively to improve outcomes for older adults undergoing surgery: a pilot and planning study.
This project aims to optimise older adults’ resilience for undergoing surgery utilising innovative gut microbiome modulation approaches (Innovate-AR), while also collecting a wealth of data for multi-omics analyses to further understand the biological connections between gut microbiome function/composition and resilience in ageing (Bio-AR).
This initial phase of the project will generate crucial pilot data and patient and participant involvement and engagement work, which, alongside the results of the remotely delivered PROMOTe trial, will be the basis of a large clinical trial funding application.
The planned BIOAGE (Bio-Interventions for Optimal Ageing and Gut Ecology) Trial is a placebo controlled double blinded trial, aiming to compare gut microbiome modulation to placebo in older surgical populations. Planned data collection, case selection and trial outcomes are to be chosen, cognisant of patient and clinician burden, while generating a wealth of data to answer key research questions
Team: Dr Mary Ni Lochlainn, Prof Kevin Whelan (LCPS), Prof Jugdeep Dhesi (GSTT), Prof Steve Harridge (BMS), Dr Natalie Cox (BMEIS)